相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FOXA1 is a key determinant of estrogen receptor function and endocrine response
Antoni Hurtado et al.
NATURE GENETICS (2011)
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Expression of Forkhead- box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores
Foluso O. Ademuyiwa et al.
MODERN PATHOLOGY (2010)
Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers
Jerrome Eeckhoute et al.
GENOME RESEARCH (2009)
Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications
S. Badve et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours
Andre Albergaria et al.
BREAST CANCER RESEARCH (2009)
FoxA1 as a lineage-specific oncogene in luminal type breast cancer
Noritaka Yamaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value
David Voduc et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance
Hany Onsy Habashy et al.
EUROPEAN JOURNAL OF CANCER (2008)
Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers
Stephen Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients
Michelle P. Wong et al.
PATHOLOGY (2008)
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis
M. A. Thorat et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study
Simon J. Crabb et al.
BREAST CANCER RESEARCH (2008)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
FOXA1 expression in breast cancer - Correlation with luminal subtype A and survival
Sunil Badve et al.
CLINICAL CANCER RESEARCH (2007)
FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer
Ido Wolf et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation
Marie-Liesse Asselin-Labat et al.
NATURE CELL BIOLOGY (2007)
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells:: potential involvement of ZEB-1 and ZEB-2
H. L. Chua et al.
ONCOGENE (2007)
FOXA1 as a therapeutic target for breast cancer
Harikrishna Nakshatri et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival
Maggie C. U. Cheang et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland
Hosein Kouros-Mehr et al.
CELL (2006)
Estrogen receptor target gene: An evolving concept
Jason S. Carroll et al.
MOLECULAR ENDOCRINOLOGY (2006)
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
A. S. Doane et al.
ONCOGENE (2006)
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1
EA Williamson et al.
ONCOGENE (2006)
Location analysis of estrogen receptor α target promoters reveals that FOXA1 defines a domain of the estrogen response
J Laganière et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
JS Carroll et al.
CELL (2005)
Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies
SK Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Predicting the clinical status of human breast cancer by using gene expression profiles
M West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer
C Lohrisch et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
